Hypothermia during RARP: No significant benefit seen
June 2nd 2017Although theory and preliminary clinical data indicated that intraoperative regional hypothermia could improve the return to potency and continence after robot-assisted radical prostatectomy, the intervention did not have any significant benefits when put to the more rigorous test of a randomized controlled trial.
Congress says 'no' to Trump NIH budget cuts
June 1st 2017The fiscal 2017 appropriations wrap-up package approved by Congress in early May included a $2 billion increase for the National Institutes of Health, despite a Trump administration request for a $1.2 billion reduction for the nation’s primary medical research facility. That bipartisan action, which funds the federal government through September, came in the face of President Trump’s demand to slash spending for domestic programs to pay for a huge increase in appropriations for defense.
Urethral lift: 5-year data point to procedure’s durability
June 1st 2017Analyses of data from 5 years of prospective follow-up in the pivotal trial supporting regulatory approval of the prostatic urethral lift ([PUL] UroLift System, NeoTract) show that the minimally invasive procedure remains safe and provides rapid and durable benefits for men with symptomatic BPH.
Harness the Power of Convective Radiofrequency Thermal Energy: How Rezūm Is Changing BPH Treatment
May 31st 2017In this Urology Times supplement, we’ll take a look at the science behind Rezūm, the nuts and bolts of the procedure, what sort of short- and long-term outcomes patients can expect following the procedure, and ways that urologists can educate their patients about this new technology.
Hospital ratings correlate with Ca surgery outcomes
May 26th 2017Medicare beneficiaries who undergo major urologic cancer surgery at hospitals with higher Hospital Compare Star Ratings introduced by the Centers for Medicare & Medicaid Services in 2016 have superior short-term outcomes than patients operated on at hospitals with lower Hospital Compare rating, according to data presented at the AUA annual meeting in Boston.
Teamwork essential if oral PCa agents are used in office setting
May 19th 2017"The nurse practitioner, nurse, and other ancillary providers who make up the urology team are an essential and valuable asset in the consideration of adding oral androgen receptor inhibitors into the office setting," writes Gwendolyn Hooper, PhD, APRN.
Urologists positive about abiraterone integration
May 19th 2017More than 96% of urologists surveyed said that incorporating abiraterone acetate (ZYTIGA) treatment into practice for patients with metastatic castrate-resistant prostate cancer is easy or manageable after overcoming initial barriers, according to new research presented at the Genitourinary Cancers Symposium in Orlando, FL.
Embolization for BPH shows long-term safety, efficacy
May 18th 2017Findings of a retrospective study including 1,000 men with follow-up ranging to 8 years demonstrate the long-term safety and efficacy of prostatic artery embolization for relieving lower urinary tract symptoms secondary to BPH, researchers reported at the Society of Interventional Radiology annual scientific meeting in Washington.
Surveillance rarely used in stage 1, 2 prostate Ca
May 18th 2017While close to 90% of men diagnosed with prostate cancer between 1998 and 2012 had stage 1 and stage 2 disease, more than 90% underwent surgery or radiation to treat the cancer, according to a study presented at the Genitourinary Cancers Symposium in Orlando, FL.
Don’t skimp on sleep: The consequences of sleep deprivation
May 17th 2017After reading an article suggesting that surgeons are similar to athletes, Henry Rosevear, MD, argues that surgeons should start treating themselves as such and also be aware of the impact poor sleep habits can have on performance.
Urologists show low adherence to value-based care pathway
May 13th 2017Urologists’ adherence to value-based care pathways for BPH surgery is extremely low and only modestly improved when given individualized feedback on patient outcomes, costs, and practice patterns relative to peers, say UCLA researchers.